Age should not affect chemotherapy choice for stage IV lung cancer: guidelines
November 20th, 2009
In an update to its 2003 guidelines for stage IV non-small-cell lung cancer (NSCLC) chemotherapy, the American Society of Clinical Oncology (ASCO) recommends that age not affect the choice of protocol.
Instead, the choice of a particular chemotherapeutic agent or combination should be based on performance status.